Altimmune, Inc.

United Statesaltimmune.com
unknown
unknown
Stage

About

Altimmune is a clinical stage biotechnology company developing next-generation vaccines using two complementary vaccine delivery platforms to address public health and biodefense needs including respiratory diseases, chronic infections, and cancer.

Explore Altimmune, Inc.'s full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.